The Pharma Source podcast dives into the latest trends, challenges, and commercial opportunities in the pharmaceutical and biotech industry

In each episode we'll be speaking with top executives, researchers, policy makers and other experts, who share their perspectives on the the trends that are shaping the business of pharma.

From the latest breakthroughs in drug development and manufacturing, to the impact of healthcare policy on drug pricing, we cover it all.

In this episode we interview Dr John LaMattina

John was president of Pfizer Global R&D- where he managed more than 13,000 scientists and professionals in the United States, Europe, and Asia.  Today, John is senior partner at PureTech Health, Author and Forbes contributor - Where he offer a unique perspective into the challenges and costs that come with bringing life-changing medicines to market.

His latest book Pharma and Profits - balancing innovation, medicine and drug prices, lays our the facts in a very accessible way, should be required reading for anyone in journalism before they write a story about drug prices.

In this interview we discuss:

- Unpacking the criticism and misconceptions about the Pharma industry 

- The lack of price transparency in the the US healthcare system

- The potential innovation-killing effects of the Inflation Reduction Act

- Why Gene Therapy is a particular issue for pricing

Subscribe to Pharma Source Podcast for your regular dose of pharma and biotech insight.

Episode ID: 1000603309312

GUID: b5dab361-941d-4393-8d3c-d9c42614a159

Release Date: 08/03/2023, 14:41:12